Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
of this position are the following: Assists with experiments investigating RNA-targeting type VI CRISPR-Cas systems. Performs molecular cloning and plasmid analysis. Conducts bacterial cell transformations and
-
of this position are the following: Assists with experiments investigating RNA-targeting type VI CRISPR-Cas systems. Performs molecular cloning and plasmid analysis. Conducts bacterial cell transformations and
-
Associate will conduct genetic, microbiological, biochemical and animal studies to identify compounds that inhibit or kill Mycobacterium tuberculosis and to better understand their targets and mechanisms
-
will conduct genetic, microbiological, biochemical and animal studies to identify compounds that inhibit or kill Mycobacterium tuberculosis and to better understand their targets and mechanisms of action
-
Associate will conduct genetic, microbiological, biochemical and animal studies to identify compounds that inhibit or kill Mycobacterium tuberculosis and to better understand their targets and mechanisms
-
for Undergraduate Programs, the Assistant Dean III applies a whole-person, student-centered framework to identify at-risk undergraduate nursing students and implement targeted coaching strategies that promote
-
signaling transduction. The current focus of the lab is the function of p53 in cellular metabolism, the functional study of several novel p53 target genes, and their contribution to tumor suppression. Through
-
learning experiences that build skills and knowledge for the targeted human service learner. Collaborates with subject matter experts, stakeholders, and other team members, as well as independent research
-
biology, enzymology, crystallographic fragment screening, and structure-guided drug discovery to define novel mechanisms of RT inhibition and develop new approaches for targeting protein–nucleic acid
-
metabolic dependencies in cancer. We discovered a targetable metabolic vulnerability that is induced downstream of mTORC1 in cancer, and can be exploited using clinically approved therapeutics to selectively